Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer.   CME information and select publications <a href="https://www.researchtopractice.com/OncologyTodayHERAlteredNSCLC25" rel="noopener noreferrer" target="_blank">here</a>.

Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer. CME information and select publications here.

Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer.&nbsp;&nbsp;&nbsp;CME information and select publications <a href="https://www.researchtopractice.com/OncologyTodayHERAlteredNSCLC25" rel="noopener noreferrer">here</a>.

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Share HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach

Sign up to save your podcasts

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach

HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach